Latest Capital Strategy News

MA Income Credit Trust (ASX, MA1) has launched a placement to raise nearly A$50 million, aiming to bolster its exposure to private credit through new unit issuance at a slight discount. The capital will fund investments across direct lending, asset-backed lending, and corporate lending segments.

Enero Group has replaced its $50 million debt facility with a smaller $15 million revolving credit line from NAB, reflecting a strategic shift towards reduced capital needs and strong cash reserves.

US Masters Residential Property Group has repatriated US$40 million from its USA Fund back to its main Australian fund, hinting at upcoming capital management decisions.

Ryder Capital Limited has announced an on-market buy-back program targeting up to 10% of its ordinary shares, signaling a strategic move in capital management.

Bank of Queensland Limited has announced a fully franked quarterly distribution of AUD 1.2415 per Capital Note 3 security, reflecting a steady income stream tied to the 3-month BBSW plus margin.

BetMakers Technology Group has launched a $1 million Share Purchase Plan (SPP) at $0.10 per share, offering eligible shareholders in Australia and New Zealand a chance to increase holdings at a discount following a $12.5 million institutional placement.

Zenith Minerals Limited has had its trading suspension lifted immediately following the release of a rights issue announcement, signaling a key capital raising move.

WCM Global Growth Limited has renewed its on-market share buy-back program for 12 months, signaling ongoing confidence in its capital management strategy amid evolving market conditions.

New World Resources has successfully completed a placement of 32 million shares at $0.02 each to its board and senior management, following shareholder approval. This move subtly reshapes the company’s capital structure ahead of its copper and base metals projects in the US.

EVT Limited has officially kicked off the sale process for its prime Sydney CBD property at 525 George Street, offering a rare mixed-use development opportunity with significant growth potential.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.

Focus Minerals has completed the sale of its Laverton Gold Project to Genesis Minerals for A$250 million in cash, marking a significant shift in its asset portfolio. The company now turns its attention to optimising operations at its Coolgardie Gold Project.